A Highly Integrated Precision Nanomedicine Strategy to Target Esophageal Squamous Cell Cancer Molecularly and Physically

The prognosis of esophageal squamous cell carcinoma is very poor. We firstly identified PI3K overexpression in patient samples and its relation to poor patient survival. With our highly versatile disulfide cross-linked micelle (DCM) based tumor-targeted drug delivery platform, we were able to load a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nanomedicine
Autors principals: WANG, Xin-shuai, DING, Xue-zhen, LI, Xiao-cen, HE, Yixuan, KONG, De-jiu, ZHANG, Li, HU, Xiao-chen, YANG, Jun-qiang, ZHAO, Meng-qi, GAO, She-gan, LIN, Tzu-yin, LI, Yuanpei
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6648684/
https://ncbi.nlm.nih.gov/pubmed/30047470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2018.06.008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars